Evaluation of the Performance of a Point-of-care A1cNOW+TM System

王晓霞,马征,洪天配,徐援,王琛,孙小萌,高洪伟,王海宁
DOI: https://doi.org/10.3969/j.issn.1006-6187.2011.11.007
2011-01-01
Abstract:Objective A1cNOW+~(TM) is a newly developed point-of-care device for glycated hemoglobin(HbA_1c) test,The aim of this study was to evaluate the performance of the device. Methods A total of 237 individuals participated in the this study.Finger prick samples were tested by the A1cNOW+~(TM) system,and the vein blood samples were tested using automatic TOSOH G7 system in the central lab.The correlation between the results of the two methods was analyzed.Precision of the A1cNOW+~(?) system were evaluated.The effects of metformin and vitamin C consumption on the performance of the device were also investigated.Results The readings of the A1cNOW+~(?) analyzer (Y) were well correlated with the HbA_1c results of the TOSOH G7(X),with the linear equation of Y= 0.9924X+0.0785,r=0.97(P0.001).Error analysis showed that the reading difference between two methods was within 0%~18.2%.The precision test revealed that the intra-lot coefficient of variation (CV) of the A1cNOW+~(?) was 2.1%~5.0%and the lot-to-lot CVs were 3.6%~3.9%.The drug interference test showed that the pre-dose readings,post-dose readings and TOSOH G7 test results in the 10 individuals taking meformin were 7.5%±1.07%,7.4%±0.99%and 7.7%±1.12%(P0.05), respectively.Conclusions A1cNOW+~(?) system holds nice accuracy,precision and anti-drug-interference ability.It is suitable for the HbA_1c testing in hospital.
What problem does this paper attempt to address?